Fitch does not rate the cl... )--FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code --AO North America Announces Jack Lewin, MD, President and Chief Executive Officer of the Cardiovascular Research Foundation as the Keynote Speaker for One AO Meeting )--Research and Markets has announced the addition of the "Analysis of the Global Web Conferencing Market -... Gilead anuncia modificacin de acuerdos con Janssen para desarrollar y comercializar los regmenes de nico comprimido basados en tenofovir alafenamida para el tratamiento del VIH )--Gilead Sciences, Inc. ha anunciado una ampliacion de acuerdo con Janssen R&D Irlanda para el desarrollo y comercializacion de un nuevo re... )--FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN ... (more)